These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 14686963

  • 1. Effects of the sibutramine therapy on pulmonary artery pressure in obese patients.
    Guven A, Koksal N, Cetinkaya A, Sokmen G, Ozdemir R.
    Diabetes Obes Metab; 2004 Jan; 6(1):50-5. PubMed ID: 14686963
    [Abstract] [Full Text] [Related]

  • 2. Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction.
    Zannad F, Gille B, Grentzinger A, Bruntz JF, Hammadi M, Boivin JM, Hanotin C, Igau B, Drouin P.
    Am Heart J; 2002 Sep; 144(3):508-15. PubMed ID: 12228789
    [Abstract] [Full Text] [Related]

  • 3. Cardiac valve evaluation and adipokine levels in obese women treated with sibutramine.
    Saraç S, Saraç F.
    Anadolu Kardiyol Derg; 2010 Jun; 10(3):226-32. PubMed ID: 20538557
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [Abstract] [Full Text] [Related]

  • 5. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K, Sibutramine in Hypertensives Clinical Study Group.
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [Abstract] [Full Text] [Related]

  • 6. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
    de Simone G, Romano C, De Caprio C, Contaldo F, Salanitri T, di Luzio Paparatti U, Pasanisi F.
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
    [Abstract] [Full Text] [Related]

  • 7. Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.
    Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP, Sibutramine/Diabetes Clinical Study Group.
    Diabetes Obes Metab; 2000 Jun; 2(3):175-87. PubMed ID: 11220553
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study.
    Hanotin C, Thomas F, Jones SP, Leutenegger E, Drouin P.
    Int J Obes Relat Metab Disord; 1998 Jan; 22(1):32-8. PubMed ID: 9481597
    [Abstract] [Full Text] [Related]

  • 9. Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment.
    Van Gaal LF, Wauters MA, De Leeuw IH.
    Exp Clin Endocrinol Diabetes; 1998 Jan; 106 Suppl 2():35-40. PubMed ID: 9792480
    [Abstract] [Full Text] [Related]

  • 10. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvárez LM.
    Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
    [Abstract] [Full Text] [Related]

  • 11. Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients--sibutramine and blood pressure.
    Birkenfeld AL, Schroeder C, Pischon T, Tank J, Luft FC, Sharma AM, Jordan J.
    Clin Auton Res; 2005 Jun; 15(3):200-6. PubMed ID: 15944869
    [Abstract] [Full Text] [Related]

  • 12. Effect of sibutramine on blood pressure in patients with obesity and well-controlled hypertension or normotension.
    Gürsoy A, Erdoğan MF, Cin MO, Cesur M, Başkal N.
    Endocr Pract; 2005 Jun; 11(5):308-12. PubMed ID: 16191490
    [Abstract] [Full Text] [Related]

  • 13. Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients.
    Nakou E, Filippatos TD, Liberopoulos EN, Tselepis AD, Kiortsis DN, Mikhailidis DP, Elisaf MS.
    Expert Opin Pharmacother; 2008 Jul; 9(10):1629-39. PubMed ID: 18570597
    [Abstract] [Full Text] [Related]

  • 14. Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).
    Sharma AM, Caterson ID, Coutinho W, Finer N, Van Gaal L, Maggioni AP, Torp-Pedersen C, Bacher HP, Shepherd GM, James WP, SCOUT Investigators.
    Diabetes Obes Metab; 2009 Mar; 11(3):239-50. PubMed ID: 18671798
    [Abstract] [Full Text] [Related]

  • 15. Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial.
    Aronne LJ, Halseth AE, Burns CM, Miller S, Shen LZ.
    Obesity (Silver Spring); 2010 Sep; 18(9):1739-46. PubMed ID: 20094043
    [Abstract] [Full Text] [Related]

  • 16. Sibutramine. A review of its contribution to the management of obesity.
    McNeely W, Goa KL.
    Drugs; 1998 Dec; 56(6):1093-124. PubMed ID: 9878996
    [Abstract] [Full Text] [Related]

  • 17. Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study.
    Hauner H, Meier M, Wendland G, Kurscheid T, Lauterbach K, Study Group SA, SAT Study.
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):201-7. PubMed ID: 15127325
    [Abstract] [Full Text] [Related]

  • 18. Effects of sibutramine on the treatment of obesity in patients with arterial hypertension.
    Faria AN, Ribeiro Filho FF, Lerario DD, Kohlmann N, Ferreira SR, Zanella MT.
    Arq Bras Cardiol; 2002 Feb; 78(2):172-80. PubMed ID: 11887193
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacological therapy of obesity].
    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [Abstract] [Full Text] [Related]

  • 20. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
    Dujovne CA, Zavoral JH, Rowe E, Mendel CM, Silbutramine Study Group.
    Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.